Current location:Home > Our Products > IMetelstat

IMetelstat

  • Name IMetelstat
  • CAS 868169-64-6
  • Purity 99%
Inquiry

Product Details

IMetelstat Good Supplier In Bulk Supply High Purity 868169-64-6 We provide high quality IMetelstat (CAS 868169-64-6), at a very affordable prices to our customers.

1.What is the IMetelstat ?

IMetelstat, also known as GRN163L, is a synthetic oligonucleotide drug that targets telomerase, an enzyme crucial for the continuous replication and immortality of cancer cells. By binding to the RNA template of telomerase, IMetelstat inhibits the enzyme's activity, thus preventing the uncontrolled growth of cancer cells. This innovative drug has demonstrated promising results in preclinical and early clinical trials for treating various cancer types, including myelofibrosis and solid tumors. IMetelstat is being explored as a potential therapeutic option for patients with advanced or refractory cancers, offering the possibility of becoming a valuable addition to existing anticancer treatments. However, further research and clinical trials are necessary to fully assess its safety and efficacy across diverse populations and cancer types.

Used in Oncology:
IMetelstat is used as an anticancer agent for targeting telomerase, an enzyme that enables the immortality and uncontrolled replication of cancer cells. By inhibiting telomerase activity, IMetelstat aims to prevent the growth and progression of various types of cancers, including myelofibrosis and solid tumors.
Used in Advanced or Refractory Cancer Treatment:
IMetelstat is being investigated as a potential therapeutic option for patients with advanced or refractory cancers, where traditional treatments may no longer be effective. Its unique mechanism of action targeting telomerase offers hope for improved treatment outcomes in these challenging cases.
Used in Preclinical and Early Clinical Trials:
IMetelstat is utilized in preclinical and early clinical trials to evaluate its safety, efficacy, and potential as a valuable addition to the current arsenal of anticancer drugs. These trials are essential for understanding the drug's performance in diverse populations and cancer types, paving the way for its potential approval and use in cancer treatment.

2.What is the CAS number for IMetelstat ?

The CAS number of IMetelstat is 868169-64-6.

More information of IMetelstat 868169-64-6 are:

CAS?Number

868169-64-6

PSA

2254.71000

LogP

20.21410

3.What is the molecular formula of IMetelstat ?

The chemical formula of?IMetelstat is C148H211N68O53P13S13 which containing 148 Carbon atoms,211 Hydrogen atoms,68 Nitrogen atoms,53 Oxygen atoms,13 Phosphorus atoms and 13 Sulfur atoms,and the molecular weight, and the molecular weight of IMetelstat is 0

4.What is IMetelstat(868169-64-6)used for?

IMetelstat, also known as GRN163L, is a synthetic oligonucleotide drug that targets telomerase, an enzyme crucial for the continuous replication and immortality of cancer cells. By binding to the RNA template of telomerase, IMetelstat inhibits the enzyme's activity, thus preventing the uncontrolled growth of cancer cells. This innovative drug has demonstrated promising results in preclinical and early clinical trials for treating various cancer types, including myelofibrosis and solid tumors. IMetelstat is being explored as a potential therapeutic option for patients with advanced or refractory cancers, offering the possibility of becoming a valuable addition to existing anticancer treatments. However, further research and clinical trials are necessary to fully assess its safety and efficacy across diverse populations and cancer types.

Relevant articles related to IMetelstat:

5.IMetelstat Good Supplier In Bulk Supply High Purity 868169-64-6

Guangdong Shunde Tongcheng New Materials Technology Co.,Ltd is a quality supplier of IMetelstat. Our main goal is customer satisfaction. Contact us to negotiate the best price for your business on IMetelstat 868169-64-6.

Related products

*Product Name
CAS
Purity
Quantity
Company name
*Email
*Other Description
*Code
The items marked with* are mandatory.
Submit